Sigma Pharmaceutical Limited
(ASX:SIP) has today revealed a strong rise in profit as the company today reported its full year figures.
A net profit of $50.3 million from continuing operations was reported for the year compared to a net loss of $73.1 million last year.
Sigma’s chief attributes the strong rise in profits to gains in market share and improved working capital.
The company will pay a final fully franked dividend of 2 cents and a special dividend of 1.5 cents payable on April 27, 2012.
